Qing Luo Selected Research

Peptides (Polypeptides)

3/2014	A synthetic mechano-growth factor E peptide promotes rat tenocyte migration by lessening cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signaling pathway.
4/2011	NAIF1 is down-regulated in gastric cancer and promotes apoptosis through the caspase-9 pathway in human MKN45 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing Luo Research Topics

Disease

57	Neoplasms (Cancer) 11/2022 - 01/2005
12	Inflammation (Inflammations) 12/2022 - 03/2011
12	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 04/2004
11	Rheumatoid Arthritis 12/2022 - 03/2017
11	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2018
11	Tuberculosis (Tuberculoses) 12/2020 - 11/2013
10	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2005
9	Rhinosinusitis 01/2021 - 01/2011
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 02/2016
8	Liver Neoplasms (Liver Cancer) 01/2022 - 04/2016
7	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2011
7	Osteosarcoma (Osteogenic Sarcoma) 01/2019 - 01/2005
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2010
6	Stomach Neoplasms (Stomach Cancer) 09/2016 - 06/2010
5	Infections 06/2022 - 11/2015
5	Leukemia 01/2012 - 03/2009
4	Carcinoma (Carcinomatosis) 11/2022 - 02/2011
4	Hypoxia (Hypoxemia) 01/2022 - 02/2015
4	Allergic Rhinitis 01/2022 - 01/2010
4	Multiple Organ Failure (MODS) 02/2015 - 11/2013
3	Corneal Neovascularization 12/2022 - 01/2022
3	Peritonitis 08/2022 - 01/2021
3	COVID-19 08/2022 - 01/2020
3	Ankylosing Spondylitis 01/2022 - 01/2019
3	Insulin Resistance 04/2019 - 10/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2016
2	Prostatic Neoplasms (Prostate Cancer) 02/2021 - 01/2020
2	Necrosis 01/2021 - 06/2016
2	Sepsis (Septicemia) 01/2021 - 01/2017
2	Asthma (Bronchial Asthma) 01/2021 - 01/2010
2	Esophageal Squamous Cell Carcinoma 05/2020 - 05/2017
2	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 01/2010
2	Hypertension (High Blood Pressure) 12/2016 - 09/2014
2	Polyps 07/2014 - 06/2012
2	Osteoporotic Fractures 11/2010 - 07/2010
2	Carcinogenesis 01/2010 - 01/2010
1	Autoimmune Diseases (Autoimmune Disease) 12/2022

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 11/2022 - 09/2011
17	Circular RNAIBA 01/2022 - 10/2017
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
13	Pharmaceutical PreparationsIBA 01/2022 - 01/2012
11	Long Noncoding RNAIBA 04/2022 - 04/2016
9	Messenger RNA (mRNA)IBA 01/2022 - 06/2010
7	Biological ProductsIBA 02/2021 - 02/2011
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2005
7	CateninsIBA 01/2021 - 01/2011
6	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2016
5	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2020
5	MucinsIBA 01/2021 - 02/2015
4	LipidsIBA 12/2022 - 12/2010
4	EnzymesIBA 01/2022 - 06/2016
3	6-methyladenineIBA 12/2022 - 01/2020
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 09/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2011
3	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2021 - 06/2016
3	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2015
3	Glucose (Dextrose)FDA LinkGeneric 07/2020 - 04/2019
3	Actins (F Actin)IBA 10/2018 - 03/2015
3	Clarithromycin (Biaxin)FDA LinkGeneric 01/2018 - 01/2011
3	OsteopontinIBA 04/2013 - 03/2011
2	Therapeutic UsesIBA 12/2022 - 12/2022
2	C-Reactive ProteinIBA 12/2022 - 01/2020
2	Caspase 3 (Caspase-3)IBA 10/2022 - 02/2021
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 04/2019
2	sinomenineIBA 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	MethyltransferasesIBA 01/2022 - 01/2012
2	ChromatinIBA 10/2021 - 08/2018
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 07/2018
2	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2013
2	salinomycinIBA 01/2021 - 01/2017
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2020 - 09/2010
2	Caveolin 1IBA 05/2020 - 09/2010
2	Glutathione (Reduced Glutathione)IBA 08/2019 - 09/2010
2	CytokinesIBA 09/2018 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2018 - 01/2018
2	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 03/2017
2	InterleukinsIBA 01/2018 - 09/2012
2	Untranslated RNA (Noncoding RNA)IBA 01/2017 - 04/2016
2	Fluorouracil (Carac)FDA LinkGeneric 10/2015 - 02/2011
2	Conditioned Culture MediaIBA 10/2015 - 03/2015
2	Apoptosis Inducing FactorIBA 06/2015 - 04/2011
2	Peptides (Polypeptides)IBA 03/2014 - 04/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2012 - 06/2012
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2010 - 04/2010
2	PPAR gammaIBA 04/2010 - 01/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2010 - 10/2009
2	Integrin beta1IBA 01/2005 - 04/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022
1	FlavonoidsIBA 12/2022
1	Sorafenib (BAY 43-9006)FDA Link 12/2022
1	isoliquiritigenin (GU 17)IBA 12/2022
1	MK 2206IBA 10/2022
1	PhosphatidylserinesIBA 10/2022

Therapy/Procedure

28	Therapeutics 12/2022 - 01/2010
7	Drug Therapy (Chemotherapy) 01/2019 - 11/2006
4	Radiotherapy 06/2022 - 01/2010
4	Immunotherapy 06/2021 - 01/2019
2	Peritoneal Dialysis 08/2022 - 02/2022
1	Oral Administration 12/2022